People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanospectra Biosciences Inc | — | Biotech / Pharma | Series A | $22.3M | $58.9M | 2017 |
Brian Pryor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Pryor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Anderson | 1 | 21 |
| J.Donald Payne | 1 | 4 |
| Patrick Pace | 1 | 3 |
| David Jorden | 1 | 3 |
| David Bristol | 1 | 2 |
| Jennifer West | 1 | 1 |
| Glenn Goodrich | 1 | 1 |
| Bradley Nyberg | 1 | 1 |
| Blair Shamel | 1 | 1 |
| Kevin P. Smith | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.